Schizophrenia; Psychosis, Persecutory Delusion
Conditions
Brief summary
The purpose of this study is to examine how Bayesian belief updating changes throughout psychotherapeutic treatment for persecutory delusions. Specifically, individuals with a psychotic disorder diagnosis who endorse both a current persecutory delusion with strong conviction and significant worry will be recruited and randomized to receive either a CBT-based worry intervention for persecutory delusions or an active control condition (befriending therapy). The investigators will examine: 1) whether belief updating parameters change as delusion severity changes, 2) whether CBT contributes to greater change in belief updating parameters than befriending therapy, and 3) whether neural correlates of belief updating parameters, as measured using functional magnetic resonance imaging (fMRI), predict treatment response.
Interventions
BEHAVIORALWorry Intervention
The worry intervention is weekly individual therapy with a trained therapist
BEHAVIORALBefriending
The worry intervention is weekly individual therapy with a trained therapist
Sponsors
Vanderbilt University Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Men and women age 18 - 65. 2. Communicative in English. 3. Premorbid Intelligence \>79 (WTAR) 4. Provide voluntary, written informed consent. 5. Physically healthy by medical history. 6. Weight \<300 lbs 7. Stable medication regimen over at least the past two weeks, including the use of either an oral or intramuscular administration of an antipsychotic medication. 8. Diagnosis of a non-affective psychotic disorder (schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, brief psychotic disorder, psychosis NOS) confirmed by Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)-5 (SCID) or diagnostic interview with a trained clinician. 9. A persecutory delusion scoring at least a 3 on the conviction scale of the Psychotic Symptoms Rating Scale (PSYRATS) that had persisted for at least two weeks and that was not considered the direct result of substance use 10. A clinically significant level of worry, as shown by a score of at least 44 on the Penn State Worry Questionnaire (PSWQ).
Exclusion criteria
1. Age less than 18 or greater than 65. 2. Not communicative in English. 3. Premorbid IQ \< 79 (WTAR) 4. Unable to provide written informed consent. 5. Current medical or neurological illness. 6. History of severe head trauma. 7. Weight \>300 lbs 8. Primary diagnosis of alcohol or substance use disorder or personality disorder 9. Conditions that preclude fMRI scanning (as defined in the fMRI Screening Form) 10. Subjects who are actively involved with individual cognitive therapy (Past experience with individual therapy is not an exclusion)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Computational Parameters of Belief Updating as Measured During a Probabilistic Reversal Learning Task | Baseline, 4 weeks, 8 weeks, 24 weeks | change in computational parameters after intervention |
| Change in Delusion Severity Utilizing the Change in Psychotic Symptoms Rating Scale (PSYRATS) | Baseline, 4 weeks, 8 weeks, 24 weeks | The change in the Delusions subscale total of the Psychotic Symptoms Rating Scale (PSYRATS) from Baseline to Week 24. The Delusions subscale is a composite score of 6 items each rated from 0-4 with 4 indicating more severe symptomology. The Delusions subscale has a possible range of 0-24. |
| Change in Neural Correlates of Belief Updating Parameters | Baseline, 8 weeks | Change in blood oxygen dependent level (BOLD) signal after intervention |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Baseline Neural Predictors of Treatment Response | Baseline | BOLD signal during belief updating task at baseline predicting treatment response |
| Resting-State Predictors of Treatment Response | Baseline | resting-state connectivity of functional networks predicting treatment response |
Countries
United States
Outcome results
None listed